Suppr超能文献

别构激活功能不对称 RAF 激酶二聚体。

Allosteric activation of functionally asymmetric RAF kinase dimers.

机构信息

Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid, Box 8118, St. Louis, MO 63110, USA; Howard Hughes Medical Institute, Washington University School of Medicine, 660 South Euclid, Box 8118, St. Louis, MO 63110, USA.

Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid, Box 8118, St. Louis, MO 63110, USA.

出版信息

Cell. 2013 Aug 29;154(5):1036-1046. doi: 10.1016/j.cell.2013.07.046.

Abstract

Although RAF kinases are critical for controlling cell growth, their mechanism of activation is incompletely understood. Recently, dimerization was shown to be important for activation. Here we show that the dimer is functionally asymmetric with one kinase functioning as an activator to stimulate activity of the partner, receiver kinase. The activator kinase did not require kinase activity but did require N-terminal phosphorylation that functioned allosterically to induce cis-autophosphorylation of the receiver kinase. Based on modeling of the hydrophobic spine assembly, we also engineered a constitutively active mutant that was independent of Ras, dimerization, and activation-loop phosphorylation. As N-terminal phosphorylation of BRAF is constitutive, BRAF initially functions to activate CRAF. N-terminal phosphorylation of CRAF was dependent on MEK, suggesting a feedback mechanism and explaining a key difference between BRAF and CRAF. Our work illuminates distinct steps in RAF activation that function to assemble the active conformation of the RAF kinase.

摘要

虽然 RAF 激酶对于控制细胞生长至关重要,但它们的激活机制尚不完全清楚。最近的研究表明,二聚化对于激活是很重要的。在这里,我们表明二聚体在功能上是不对称的,一个激酶作为激活剂来刺激伙伴受体激酶的活性。激活激酶不需要激酶活性,但需要 N 端磷酸化,这种磷酸化具有变构作用,诱导受体激酶的顺式自磷酸化。基于疏水脊柱组装的建模,我们还设计了一种组成型激活突变体,该突变体不依赖于 Ras、二聚化和激活环磷酸化。由于 BRAF 的 N 端磷酸化是组成型的,因此 BRAF 最初的作用是激活 CRAF。CRAF 的 N 端磷酸化依赖于 MEK,这表明存在一种反馈机制,解释了 BRAF 和 CRAF 之间的一个关键区别。我们的工作阐明了 RAF 激活的不同步骤,这些步骤共同作用以组装 RAF 激酶的活性构象。

相似文献

1
Allosteric activation of functionally asymmetric RAF kinase dimers.
Cell. 2013 Aug 29;154(5):1036-1046. doi: 10.1016/j.cell.2013.07.046.
2
Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF.
Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6067-72. doi: 10.1073/pnas.1102554108. Epub 2011 Mar 25.
3
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.
Nature. 2010 Mar 18;464(7287):427-30. doi: 10.1038/nature08902.
4
ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers.
Oncogene. 2013 Jun 27;32(26):3207-12. doi: 10.1038/onc.2012.330. Epub 2012 Aug 27.
5
A dimerization-dependent mechanism drives RAF catalytic activation.
Nature. 2009 Sep 24;461(7263):542-5. doi: 10.1038/nature08314. Epub 2009 Sep 2.
6
MEK drives BRAF activation through allosteric control of KSR proteins.
Nature. 2018 Feb 22;554(7693):549-553. doi: 10.1038/nature25478. Epub 2018 Feb 12.
7
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
Nature. 2010 Mar 18;464(7287):431-5. doi: 10.1038/nature08833. Epub 2010 Feb 3.
8
Analyses of the oncogenic BRAF variant reveal a kinase-independent function of BRAF in activating MAPK signaling.
J Biol Chem. 2020 Feb 21;295(8):2407-2420. doi: 10.1074/jbc.RA119.011536. Epub 2020 Jan 12.
9
Regulation of RAF family kinases: new insights from recent structural and biochemical studies.
Biochem Soc Trans. 2024 Jun 26;52(3):1061-1069. doi: 10.1042/BST20230552.
10
Stabilization of a closed kinase conformation induces RAF dimerization.
Cancer Discov. 2013 Jul;3(7):715. doi: 10.1158/2159-8290.CD-RW2013-114. Epub 2013 May 30.

引用本文的文献

3
Characterization and inhibitor sensitivity of ARAF, BRAF, and CRAF complexes.
bioRxiv. 2025 Aug 17:2025.08.14.670349. doi: 10.1101/2025.08.14.670349.
6
Oncogenic non-V600 mutations evade the regulatory machinery of RAF including the Cdc37/Hsp90 chaperone and the 14-3-3 scaffold.
Theranostics. 2025 Jan 6;15(5):2035-2051. doi: 10.7150/thno.103958. eCollection 2025.
7
Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer.
Mol Oncol. 2025 Jun;19(6):1751-1774. doi: 10.1002/1878-0261.13814. Epub 2025 Jan 28.
8
Role of the αC-β4 loop in protein kinase structure and dynamics.
Elife. 2024 Dec 4;12:RP91980. doi: 10.7554/eLife.91980.
10
Experimental variables determine the outcome of RAS-RAS interactions.
J Biol Chem. 2024 Nov;300(11):107859. doi: 10.1016/j.jbc.2024.107859. Epub 2024 Oct 5.

本文引用的文献

1
MEK-1 activates C-Raf through a Ras-independent mechanism.
Biochim Biophys Acta. 2013 May;1833(5):976-86. doi: 10.1016/j.bbamcr.2013.01.015. Epub 2013 Jan 27.
2
Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling.
Mol Cell. 2013 Feb 21;49(4):751-8. doi: 10.1016/j.molcel.2012.12.018. Epub 2013 Jan 24.
3
ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers.
Oncogene. 2013 Jun 27;32(26):3207-12. doi: 10.1038/onc.2012.330. Epub 2012 Aug 27.
4
Identification of a novel family of BRAF(V600E) inhibitors.
J Med Chem. 2012 Jun 14;55(11):5220-30. doi: 10.1021/jm3004416. Epub 2012 May 18.
5
RAF inhibitor-induced KSR1/B-RAF binding and its effects on ERK cascade signaling.
Curr Biol. 2011 Apr 12;21(7):563-8. doi: 10.1016/j.cub.2011.02.033. Epub 2011 Mar 31.
6
Single substitution within the RKTR motif impairs kinase activity but promotes dimerization of RAF kinase.
J Biol Chem. 2011 May 6;286(18):16491-503. doi: 10.1074/jbc.M110.194167. Epub 2011 Mar 18.
7
A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK.
Nature. 2011 Apr 21;472(7343):366-9. doi: 10.1038/nature09860. Epub 2011 Mar 27.
8
Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF.
Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6067-72. doi: 10.1073/pnas.1102554108. Epub 2011 Mar 25.
9
Protein kinases: evolution of dynamic regulatory proteins.
Trends Biochem Sci. 2011 Feb;36(2):65-77. doi: 10.1016/j.tibs.2010.09.006. Epub 2010 Oct 23.
10
Partner exchange: protein-protein interactions in the Raf pathway.
Trends Biochem Sci. 2010 Dec;35(12):660-8. doi: 10.1016/j.tibs.2010.06.001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验